The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ASNA, RMED and PYX

NEW YORK, NY / ACCESSWIRE / June 18, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Ascena Retail Group, Inc. (ASNA)
Class Period: September 16, 2015 to June 8, 2017
Lead Plaintiff Deadline: August 6, 2019

The lawsuit alleges Ascena Retail Group, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (a) the ANN Acquisition was a complete disaster for the Company as Ann's operations were in far worse condition than had been represented to the public; (b) in order to mask the true condition of Ann, Defendants improperly delayed recognizing an impairment charge to the value of Ann's goodwill and, as a result, Ascena's reported income and assets were materially overstated and the Company's financial results were not prepared in conformity with GAAP; (c) many of the brands acquired in the ANN Acquisition were in steep decline and were also materially overvalued on Ascena's Class Period financial statements; and (d) as a result of the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company, its operations and prospects.

Get additional information about the ASNA lawsuit: http://www.kleinstocklaw.com/pslra-1/ascena-retail-group-inc-loss-submission-form?id=1987&from=1

Ra Medical Systems, Inc. (RMED)
Class Period: stockholders that purchased Ra Medical securities pursuant and/or traceable to the Company's September 2018 initial public offering.
Lead Plaintiff Deadline: August 6, 2019

Throughout the class period, Ra Medical Systems, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's evaluation of sales personnel candidates was inadequate; (2) the Company's training program for sales personnel was inadequate; (3) as a result, the Company could not reasonably assure that its newly hired sales personnel were adequately experienced; (4) as a result, the Company would suffer a shortage of qualified sales personnel; (5) the Company's manufacturing process could not reasonably support increased catheter production; (6) as a result, the Company would suffer production delays; and (7) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Get additional information about the RMED lawsuit: http://www.kleinstocklaw.com/pslra-1/ra-medical-systems-inc-loss-submission-form?id=1987&from=1

Pyxus International, Inc. (PYX)
Class Period: on behalf of stockholders who purchased Pyxus (f/k/a Alliance One International, Inc. (AOI)) securities between June 7, 2018 and November 8, 2018, inclusive.
Lead Plaintiff Deadline: August 6, 2019

Pyxus International, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing longer shipping cycles; (2) as a result, the Company's financial results would be materially affected; (3) the Company lacked adequate internal control over financial reporting; (4) the Company's accounting policies were reasonably likely to lead to regulatory scrutiny; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Get additional information about the PYX lawsuit: http://www.kleinstocklaw.com/pslra-1/pyxus-international-inc-f-k-a-alliance-one-international-inc-loss-submission-form?id=1987&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.